Lui VWY - Search Results

1

Precision drugging of the MAPK pathway in head and neck cancer.

Ngan HL, Law CH, Choi YCY, Chan JY, Lui VWY. Ngan HL, et al. Among authors: lui vwy. NPJ Genom Med. 2022 Mar 16;7(1):20. doi: 10.1038/s41525-022-00293-1. NPJ Genom Med. 2022. PMID: 35296678 Free PMC article. Review.

2

Genomic Landscapes of EBV-Associated Nasopharyngeal Carcinoma vs. HPV-Associated Head and Neck Cancer.

Ngan HL, Wang L, Lo KW, Lui VWY. Ngan HL, et al. Among authors: lui vwy. Cancers (Basel). 2018 Jun 21;10(7):210. doi: 10.3390/cancers10070210. Cancers (Basel). 2018. PMID: 29933636 Free PMC article. Review.

3

Erlotinib sensitivity of MAPK1p.D321N mutation in head and neck squamous cell carcinoma.

Ngan HL, Poon PHY, Su YX, Chan JYK, Lo KW, Yeung CK, Liu Y, Wong E, Li H, Lau CW, Piao W, Lui VWY. Ngan HL, et al. Among authors: lui vwy. NPJ Genom Med. 2020 Apr 20;5(1):17. doi: 10.1038/s41525-020-0124-5. eCollection 2020. NPJ Genom Med. 2020. PMID: 32351709 Free PMC article.

4

MAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signaling.

Ngan HL, Liu Y, Fong AY, Poon PHY, Yeung CK, Chan SSM, Lau A, Piao W, Li H, Tse JSW, Lo KW, Chan SM, Su YX, Chan JYK, Lau CW, Mills GB, Grandis JR, Lui VWY. Ngan HL, et al. Among authors: lui vwy. Life Sci Alliance. 2020 May 7;3(6):e201900545. doi: 10.26508/lsa.201900545. Print 2020 Jun. Life Sci Alliance. 2020. PMID: 32381551 Free PMC article.

5

Comprehensive Exome Analysis of Immunocompetent Metastatic Head and Neck Cancer Models Reveals Patient Relevant Landscapes.

Li H, Ngan HL, Liu Y, Chan HHY, Poon PHY, Yeung CK, Peng Y, Lam WY, Li BX, He Y, Lui VWY. Li H, et al. Among authors: lui vwy. Cancers (Basel). 2020 Oct 12;12(10):2935. doi: 10.3390/cancers12102935. Cancers (Basel). 2020. PMID: 33053752 Free PMC article.

6

[No title available]

[No authors listed] [No authors listed] PMID: 33579954

7

Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis.

Wen YH, Lin HQ, Li H, Zhao Y, Lui VWY, Chen L, Wu XM, Sun W, Wen WP. Wen YH, et al. Among authors: lui vwy. Cancer Immunol Immunother. 2019 Feb;68(2):221-232. doi: 10.1007/s00262-018-2265-2. Epub 2018 Oct 25. Cancer Immunol Immunother. 2019. PMID: 30357458 Free PMC article.

8

The cylindromatosis (CYLD) gene and head and neck tumorigenesis.

Verhoeft KR, Ngan HL, Lui VWY. Verhoeft KR, et al. Among authors: lui vwy. Cancers Head Neck. 2016 Sep 8;1:10. doi: 10.1186/s41199-016-0012-y. eCollection 2016. Cancers Head Neck. 2016. PMID: 31093340 Free PMC article. Review.

9

Head and neck squamous cell carcinoma.

Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Johnson DE, et al. Among authors: lui vwy. Nat Rev Dis Primers. 2020 Nov 26;6(1):92. doi: 10.1038/s41572-020-00224-3. Nat Rev Dis Primers. 2020. PMID: 33243986 Free PMC article. Review.

10

A Novel Bayesian Framework Infers Driver Activation States and Reveals Pathway-Oriented Molecular Subtypes in Head and Neck Cancer.

Liu Z, Cai C, Ma X, Liu J, Chen L, Lui VWY, Cooper GF, Lu X. Liu Z, et al. Among authors: lui vwy. Cancers (Basel). 2022 Oct 3;14(19):4825. doi: 10.3390/cancers14194825. Cancers (Basel). 2022. PMID: 36230748 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page